MedPath

Performance Monitoring and Response Inhibition in Cannabis Dependent Patients: An Event-Related Brain Potential Study

Conditions
middelen afhankelijkheid
cannabis addiction
cannabis dependence
Registration Number
NL-OMON37592
Lead Sponsor
Erasmus Universiteit Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1) Signed informed consent
2) Age between 18 and 25 years old
3) Normal or corrected-to-normal vision (is able to read presented text in EEG task easily)
4) Being a sigaterette smoker (at least 3 sigarettes in a week);Additional criterium for patient-group
5) Meeting the DSM-IV criteria of cannabis dependence

Exclusion Criteria

1) History of significant medical illness and/or psychiatric disorders
2) Psychotropic medication
3) Alcohol use within 24 hours of the day of testing
4) Nicotine use within 3 hours of the experiment;Patient group
5) Meeting the DSM-lV criteria for dependence on other substances than nicotine or cannabis;Control group
5) Meeting the DSM-lV criteria for dependence on other substances than nicotine

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main study parameters are ERP modulations in response to the Go/NoGo and<br /><br>Eriksen Flanker Task. The end of this study will be reached when 60<br /><br>participants are included and tested successfully.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>To investigate whether there is a correlation with the amount and years of use<br /><br>on the one hand and the degree of errors and diminished neural correlates on<br /><br>the other hand. To investigate whether there is a correlation with the amount<br /><br>and years of use on the one hand and the degree of response inhibition on the<br /><br>other hand.</p><br>
© Copyright 2025. All Rights Reserved by MedPath